DXCM
VENTE TOTALE: 54 524 titres (~4 531 522,41 $ US)
- Insiders
- SAYER KEVIN R, Heller Bridgette P
- Total bought
- —
- Total sold
- $4,531,522
- Last activity
- 2026-08-20
- Last synced
-
2026-08-26 03:23:35
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Neutral signal Scored 2026-08-31
DXCM presents genuinely strong financial fundamentals in 2025 — margin expansion, deleveraging, and improved operational efficiency — which anchor a solid base score.
The first sentence of the analysis written for DXCM on 2026-08-31 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 60.1% | 60.5% | 63.2% | 64.7% | 68.6% | |
| Ebit Margin | 23.7% | 18.1% | 20.2% | 14.1% | 11.3% | |
| Ebitda Margin | 29.1% | 23.4% | 25.3% | 19.4% | 15.4% | |
| Operating Profit Margin | 19.6% | 14.9% | 16.5% | 13.4% | 10.9% | |
| Pretax Profit Margin | 23.3% | 17.6% | 19.6% | 13.4% | 10.5% | |
| Continuous Operations Profit Margin | 17.9% | 14.3% | 14.9% | 11.7% | 8.9% | |
| Net Profit Margin | 17.9% | 14.3% | 14.9% | 11.7% | 8.9% | |
| Bottom Line Profit Margin | 18.2% | 14.6% | 15.3% | 12.1% | 9.3% | |
| Current Ratio | 1.883 | 1.467 | 2.844 | 1.995 | 5.112 | |
| Quick Ratio | 1.589 | 1.282 | 2.485 | 1.828 | 4.616 | |
| Solvency Ratio | 0.303 | 0.181 | 0.173 | 0.152 | 0.110 | |
| Cash Ratio | 0.428 | 0.207 | 0.364 | 0.349 | 1.460 | |
| Price To Earnings Ratio | 31.014 | 53.267 | 86.174 | 128.682 | 239.714 | |
| Price To Earnings Growth Ratio | 0.666 | 38.352 | 1.354 | 2.252 | -4.187 | |
| Forward Price To Earnings Growth Ratio | 0.666 | 38.352 | 1.354 | 2.252 | -4.187 | |
| Price To Earnings Diluted Ratio | 31.756 | 54.768 | 95.454 | 141.550 | 263.216 | |
| Price To Earnings Diluted Growth Ratio | 0.673 | 5.933 | 1.527 | 2.489 | -4.398 | |
| Price To Book Ratio | 9.431 | 14.966 | 23.155 | 20.685 | 25.433 | |
| Price To Sales Ratio | 5.555 | 7.803 | 13.223 | 15.154 | 21.212 | |
| Price To Free Cash Flow Ratio | 24.042 | 49.893 | 93.571 | 144.718 | 974.436 | |
| Price To Operating Cash Flow Ratio | 17.976 | 31.802 | 63.993 | 65.864 | 117.373 | |
| Debt To Assets Ratio | 0.219 | 0.399 | 0.414 | 0.398 | 0.437 | |
| Debt To Equity Ratio | 0.506 | 1.231 | 1.254 | 1.006 | 1.057 | |
| Debt To Capital Ratio | 0.336 | 0.552 | 0.556 | 0.502 | 0.514 | |
| Long Term Debt To Capital Ratio | 0.311 | 0.370 | 0.541 | 0.360 | 0.493 | |
| Financial Leverage Ratio | 2.309 | 3.084 | 3.028 | 2.529 | 2.416 | |
| Working Capital Turnover Ratio | 2.860 | 1.903 | 1.542 | 1.214 | 0.848 | |
| Operating Cash Flow Ratio | 0.672 | 0.337 | 0.481 | 0.364 | 0.614 | |
| Operating Cash Flow Sales Ratio | 0.309 | 0.245 | 0.207 | 0.230 | 0.181 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.748 | 0.637 | 0.684 | 0.455 | 0.120 | |
| Debt Service Coverage Ratio | 60.459 | 0.664 | 36.837 | 0.652 | 17.957 | |
| Interest Coverage Ratio | 49.825 | 31.579 | 29.443 | 21.032 | 14.138 | |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 0.822 | 0.000 | 0.867 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 1.037 | 0.382 | 0.289 | 0.312 | 0.205 | |
| Capital Expenditure Coverage Ratio | 3.963 | 2.758 | 3.164 | 1.835 | 1.137 | |
| Dividend Paid And Capex Coverage Ratio | 3.963 | 2.758 | 3.164 | 1.835 | 1.137 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | 19.411 | 35.370 | 54.463 | 80.662 | 140.511 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 60.1% | ▼-0.4% | ▼-3.3% |
| Ebit Margin | 23.7% | ▲5.7% | ▲6.3% |
| Ebitda Margin | 29.1% | ▲5.7% | ▲6.6% |
| Operating Profit Margin | 19.6% | ▲4.7% | ▲4.5% |
| Pretax Profit Margin | 23.4% | ▲5.8% | ▲6.5% |
| Continuous Operations Profit Margin | 17.9% | ▲3.6% | ▲4.4% |
| Net Profit Margin | 17.9% | ▲3.6% | ▲4.4% |
| Bottom Line Profit Margin | 18.2% | ▲3.6% | ▲4.3% |
| Current Ratio | 1.883 | ▲0.415 | ▼-0.777 |
| Quick Ratio | 1.589 | ▲0.307 | ▼-0.771 |
| Solvency Ratio | 0.303 | ▲0.122 | ▲0.119 |
| Cash Ratio | 0.428 | ▲0.222 | ▼-0.133 |
| Price To Earnings Ratio | 31.014 | ▼-22.253 | ▼-76.756 |
| Price To Earnings Growth Ratio | 0.666 | ▼-37.686 | ▼-7.022 |
| Forward Price To Earnings Growth Ratio | 0.666 | ▼-37.686 | ▼-7.022 |
| Price To Earnings Diluted Ratio | 31.756 | ▼-23.012 | ▼-85.593 |
| Price To Earnings Diluted Growth Ratio | 0.673 | ▼-5.260 | ▼-0.572 |
| Price To Book Ratio | 9.431 | ▼-5.535 | ▼-9.303 |
| Price To Sales Ratio | 5.555 | ▼-2.248 | ▼-7.034 |
| Price To Free Cash Flow Ratio | 24.042 | ▼-25.852 | ▼-233.290 |
| Price To Operating Cash Flow Ratio | 17.976 | ▼-13.826 | ▼-41.426 |
| Debt To Assets Ratio | 0.219 | ▼-0.180 | ▼-0.154 |
| Debt To Equity Ratio | 0.506 | ▼-0.725 | ▼-0.505 |
| Debt To Capital Ratio | 0.336 | ▼-0.216 | ▼-0.156 |
| Long Term Debt To Capital Ratio | 0.311 | ▼-0.059 | ▼-0.104 |
| Financial Leverage Ratio | 2.309 | ▼-0.775 | ▼-0.364 |
| Working Capital Turnover Ratio | 2.860 | ▲0.957 | ▲1.187 |
| Operating Cash Flow Ratio | 0.672 | ▲0.335 | ▲0.179 |
| Operating Cash Flow Sales Ratio | 0.309 | ▲0.064 | ▲0.075 |
| Free Cash Flow Operating Cash Flow Ratio | 0.748 | ▲0.110 | ▲0.219 |
| Debt Service Coverage Ratio | 60.459 | ▲59.795 | ▲37.145 |
| Interest Coverage Ratio | 49.825 | ▲18.246 | ▲20.622 |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | ▼-0.822 | ▼-0.338 |
| Operating Cash Flow Coverage Ratio | 1.037 | ▲0.654 | ▲0.592 |
| Capital Expenditure Coverage Ratio | 3.963 | ▲1.206 | ▲1.392 |
| Dividend Paid And Capex Coverage Ratio | 3.963 | ▲1.206 | ▲1.392 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | 19.411 | ▼-15.959 | ▼-46.672 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $25.90B | $31.47B | $47.90B | $44.10B | $51.94B | |
| Enterprise value | $26.37B | $33.45B | $49.93B | $45.60B | $53.04B | |
| EV / Sales | 5.66x | 8.29x | 13.78x | 15.67x | 21.66x | |
| EV / Op. cash flow | 18.30x | 33.80x | 66.70x | 68.11x | 119.87x | |
| EV / Free cash flow | 24.48x | 53.03x | 97.53x | 149.65x | 995.17x | |
| EV / EBITDA | 19.41x | 35.37x | 54.46x | 80.66x | 140.51x | |
| Net debt / EBITDA | 0.35x | 2.10x | 2.21x | 2.66x | 2.93x | |
| Current ratio | 1.88x | 1.47x | 2.84x | 2.00x | 5.11x | |
| Income quality | 1.72x | 1.72x | 1.38x | 1.96x | 2.86x | |
| Graham number | $18 | $13 | $13 | $10 | $8 | |
| Graham net-net | -$1 | -$2 | -$1 | -$0 | $1 | |
| Tax burden | 76.8% | 81.3% | 76.2% | 87.3% | 84.5% | |
| Interest burden | 98.3% | 97.4% | 97.2% | 95.5% | 93.2% | |
| Working capital | $1.89B | $1.37B | $2.87B | $1.83B | $2.96B | |
| Invested capital | $3.62B | $2.90B | $4.21B | $3.16B | $3.91B | |
| Return on assets | 13.2% | 8.9% | 8.6% | 6.3% | 4.4% | |
| Operating ROA | 14.2% | 9.4% | 10.3% | 7.6% | 5.8% | |
| Return on tangible assets | 13.4% | 9.1% | 8.9% | 6.6% | 4.4% | |
| Return on equity | 30.5% | 27.4% | 26.2% | 16.0% | 10.6% | |
| Return on invested capital | 16.6% | 10.2% | 9.6% | 7.9% | 5.3% | |
| Return on capital employed | 21.7% | 16.9% | 12.7% | 11.0% | 6.3% | |
| Earnings yield | 3.2% | 1.8% | 1.1% | 0.8% | 0.4% | |
| Free cash flow yield | 4.2% | 2.0% | 1.1% | 0.7% | 0.1% | |
| Capex / Op. cash flow | 25.2% | 36.3% | 31.6% | 54.5% | 88.0% | |
| Capex / Depreciation | 144.4% | 164.8% | 127.2% | 234.0% | 381.6% | |
| Capex / Sales | 7.8% | 8.9% | 6.5% | 12.5% | 15.9% | |
| SG&A / Sales | 27.7% | 31.9% | 32.7% | 34.6% | 33.1% | |
| R&D / Sales | 12.9% | 13.7% | 14.0% | 16.6% | 24.7% | |
| Stock comp / Sales | 3.4% | 4.2% | 4.2% | 4.3% | 4.6% | |
| Intangibles / Total assets | 1.5% | 1.9% | 2.5% | 3.7% | 1.2% | |
| Days sales outstanding | 101d | 94d | 100d | 94d | 77d | |
| Days payables outstanding | 68d | 79d | 76d | 85d | 90d | |
| Operating cycle | 224d | 218d | 253d | 203d | 247d | |
| Cash conversion cycle | 157d | 139d | 177d | 119d | 157d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▼-17.7%EV / Sales ▼-31.8%EV / EBITDA ▼-45.1%EV / Op. cash flow ▼-15.501Earnings yield ▲+0.014Graham number ▲+5.519
Profitability
Return on equity ▲+0.031Return on assets ▲+0.043Return on invested capital ▲+0.064Return on capital employed ▲+0.048Operating ROA ▲+0.048Income quality ▲+0.005Tax burden ▼-0.044
Efficiency
Days sales outstanding ▲+7.445Days payables outstanding ▼-11.468Operating cycle ▲+6.707Cash conversion cycle ▲+18.175Capex / Sales ▼-0.011R&D / Sales ▼-0.008
Balance-sheet strength
Current ratio ▲+0.415Net debt / EBITDA ▼-1.748Working capital ▲+521400000.000Invested capital ▲+724800000.000Intangibles / Total assets ▼-0.004
Change over 5 years
Valuation
Market cap ▼-50.1%EV / Sales ▼-73.9%EV / EBITDA ▼-86.2%EV / Op. cash flow ▼-101.567Earnings yield ▲+0.028Graham number ▲+10.262
Profitability
Return on equity ▲+0.198Return on assets ▲+0.088Return on invested capital ▲+0.113Return on capital employed ▲+0.154Operating ROA ▲+0.085Income quality ▼-1.138Tax burden ▼-0.076
Efficiency
Days sales outstanding ▲+23.980Days payables outstanding ▼-22.454Operating cycle ▼-22.385Cash conversion cycle ▲+0.069Capex / Sales ▼-0.081R&D / Sales ▼-0.118
Balance-sheet strength
Current ratio ▼-3.229Net debt / EBITDA ▼-2.581Working capital ▼-1072800000.000Invested capital ▼-288400000.000Intangibles / Total assets ▲+0.003
Employee count
Peer market caps
Congressional trades
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2026-05-01 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2026-04-13 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2026-01-29 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-09-29 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2025-09-22 | Michael McCaul | Purchase | $1,001 - $15,000 |
| 2025-06-16 | Michael McCaul | Sale | $15,001 - $50,000 |
| 2025-06-02 | Michael McCaul | Purchase | $15,001 - $50,000 |
| 2025-05-15 | Rob Bresnahan | Purchase | $1,001 - $15,000 |
| 2025-04-08 | Michael McCaul | Purchase | $50,001 - $100,000 |
| 2025-04-08 | Rob Bresnahan | Sale | $1,001 - $15,000 |
| 2025-04-07 | Jefferson Shreve | Sale | $15,001 - $50,000 |
| 2025-03-13 | Michael McCaul | Purchase | $15,001 - $50,000 |
| 2025-02-25 | Rob Bresnahan | Purchase | $1,001 - $15,000 |
| 2024-12-31 | Kevin Hern | Sale (Full) | $50,001 - $100,000 |
| 2024-09-09 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2024-09-09 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-10-31 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-10-10 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-10-02 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-09-12 | Josh Gottheimer | Sale | $1,001 - $15,000 |
| 2023-09-06 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-08-29 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-05-23 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-12-05 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-10-21 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-10-20 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-09-29 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-09-28 | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2022-08-23 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-08-01 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-07-19 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2022-06-17 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-05-23 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-05-10 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-05-05 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-02-17 | Ro Khanna | Purchase | $15,001 - $50,000 |
| 2022-02-14 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-01-21 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-01-11 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2021-07-01 | Kevin Hern | Purchase | $100,001 - $250,000 |
| 2021-02-16 | Peter Meijer | Sale (Full) | $1,001 - $15,000 |
| 2020-12-24 | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2020-12-22 | Gilbert Cisneros | Sale (Full) | $1,001 - $15,000 |
| 2020-10-02 | Susie Lee | Sale (Full) | $1,001 - $15,000 |
| 2020-09-16 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2020-08-13 | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2020-05-11 | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2019-07-16 | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2019-06-20 | Bradley S. Schneider | Sale (Full) | $100,001 - $250,000 |
| 2019-06-13 | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2017-06-20 | Bradley S. Schneider | Purchase | $100,001 - $250,000 |
Recent news
- 2026-08-25 Abbott vs. DexCom: Which CGM Stock Is the Better Buy Now? ABT edges DXCM on price-target upside and valuation, while both pursue CGM growth through innovation, adoption and strong liquidity.
- 2026-08-24 Great Lakes Advisors LLC Invests $369,000 in DexCom, Inc. $DXCM Great Lakes Advisors LLC purchased a new position in shares of DexCom, Inc. (NASDAQ: DXCM) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 5,472 shares of the medical device company''s stock, valued at approximately $369,000. Other hedge funds also recently added to
- 2026-08-21 Here''s Why DexCom (DXCM) is a Strong Momentum Stock The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here''s why you should take advantage.
- 2026-08-20 The Big 3: PH, DXCM, UNP Dan Deming discusses why he sees sideways action in the stock market continuing through next week, noting anticipating for the Fed''s Jackson Hole meeting. As for Thursday''s Big 3, he sees an opportunity in Parker-Hannifin (PH) closing its stock gap, Dexcom (DXCM) maintaining recent upward momentum, and Union Pacific (UNP) becoming a leader in the railroad industry''s comeback.
- 2026-08-20 Aurora Investment Counsel Invests $2.34 Million in DexCom, Inc. $DXCM Aurora Investment Counsel bought a new stake in DexCom, Inc. (NASDAQ: DXCM) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 34,744 shares of the medical device company''s stock, valued at approximately $2,340,000. DexCom comprises 1.2% of Aurora Investment Counsel''s investment portfolio, making
- 2026-08-13 Here''s Why DexCom (DXCM) is a Strong Growth Stock Whether you''re a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 2026-08-12 Is DXCM Stock Worth Buying as Growth Improves but Valuation Stretches? DexCom''s broader CGM coverage, G7 15 Day rollout and rising margins support growth, but premium valuation, competition and litigation temper upside.
- 2026-08-12 Can DexCom''s Raised 2026 Outlook Sustain Stronger Margin Momentum? DexCom raises its 2026 revenue and margin outlook as G7 15 Day efficiencies lift profitability, while FX and transition costs remain key tests.
- 2026-08-12 DXCM Rallies 52.5% in 3 Months. Can the Stock Keep Climbing From Here? DexCom''s 52.5% three-month rally is backed by earnings growth and margin gains, but premium valuation, competition and litigation raise the bar.
- 2026-08-12 DXCM Stock Up Nearly 35% YTD: Will the Uptrend Continue in the Rest of 2026? DXCM''s 2026 rebound is backed by stronger growth, G7 15 Day adoption and broader CGM access, but competition and reimbursement remain key risks.